Overview
Against the backdrop of COVID-19, telehealth partnerships and transactions are taking center stage in today’s dynamic market. These deals present unique valuation issues, however, they are subject to a complex array of state and federal fraud and abuse laws and corporate practice of medicine prohibitions.
In this fourth installment of our webinar series, we’ll analyze telehealth deal structures and the role of valuation firms, and review available market comparability resources to guide the valuation outcomes.
Our seasoned lawyers will discuss:
- Services being used for telehealth and virtual care
- Valuation needs and market trends
- Compensation arrangements
- Innovative collaborations and how they are affecting valuations
